Interesting CRWD Put And Call Options For June 2028

CrowdStrike (CRWD) is being highlighted for option-income strategies: a $450 put is bid at $98.10 with the stock trading at $455.29, implying a reported cost basis of $351.90 if assigned and a 69% chance to expire worthless; the put's YieldBoost is cited as 21.80% (8.92% annualized). On the call side, a $550 strike is bid at $104.65 — a covered-call sale against shares bought at $455.29 would produce a stated 43.79% total return if called in June 2028, with a 42% chance to expire worthless and a 22.99% (9.41% annualized) YieldBoost. Implied volatility is ~46% (put) and ~45% (call) versus a 12-month trailing volatility of 45%; StockOptionsChannel will track odds and histories on its contract pages.

Analysis

Market structure: Option sellers and yield-seeking allocators directly benefit — selling the Jun‑2028 CRWD 450 put collects $98.10 (~21.8% credit, 8.92% annualized) while covered‑call sellers can boost returns ~22.99% (9.41% annualized) by selling the 550 call for $104.65. Exchanges, option market‑makers and margin lenders gain fee and financing income; long-only tech holders face capped upside if covered calls proliferate. With IV ≈45% ≈ realized vol, the market is pricing current cyclicality rather than a volatility shock, implying neutral skew and limited convexity premium to arbitrage.

Risk assessment: Tail risks include a macro recession or a major security breach that could compress CRWD revenue growth >300 bps and plunge shares below the 350s, vaporizing put‑seller equity; regulatory actions on telemetry/privacy could also re-rate multiples by 20–40% over 6–24 months. Short term (days–weeks) option flows and delta hedging can create 5–10% price moves around liquidity events; medium term (months) outcomes hinge on ARR/renewal beats or misses, and long term (≥1 year) on product moat vs PANW/ZS and execution on margin expansion. Hidden dependency: assigned positions concentrate equity ownership and funding needs (each put = $45k notional), amplifying liquidity strain if rolls are forced.

Trade implications: Direct play — sell the Jun‑2028 450 puts only if willing to own at net $351.90 and size per contract equals ~$45k cash allocation; consider rolling if stock <400. Use bull‑put spreads (sell 450 / buy 350) to cap tail risk when selling premium; IV being roughly fair argues for premium harvesting but not naked short‑gamma on large size. For pairs, favor long CRWD vs short ZS for 6–12 months if CRWD sustains >20% ARR growth differential; trim if relative spread tightens by 10%.

Key Decisions for Investors

• Sell-to-open 1–3 Jun‑2028 CRWD 450 puts (ticker CRWD) per $100k cash sleeve to collect ~$98.10 premium (net assignment basis $351.90) only if willing to own at that basis; set hard stop: buy to close if CRWD < 400 or IV collapses below 35% within 30 days.
• Initiate a buy‑stock + sell‑call covered trade: establish a 1–2% NAV long CRWD position and sell Jun‑2028 550 calls (collect ~$104.65) to target 43.8% total return if called; close the covered call early if stock >520 or after an earnings beat that raises guidance.
• If unwilling to accept full assignment tail risk, implement a Jun‑2028 450/350 bull‑put spread (sell 450 put, buy 350 put) to reduce max loss to (width − credit) and cap required cash per contract to ~$45k; target net credit ≥$60 to keep max loss ≤$40k per contract.
• Establish a 6–12 month pair trade: long CRWD / short ZS sized 1:1 (total exposure 1–2% NAV) to exploit relative execution/endpoint strength; exit if CRWD/ZS spread narrows by 10% or if CRWD ARR growth underperforms by >200 bps at next quarterly report.
• Trigger rules: reduce all CRWD option exposure by 50% within 3 trading days if quarterly billings/revenue guidance misses consensus by >5% or if material security incident announced (time horizon immediate).